Kristina Markova, Novartis (R);
Christos Haritoglou, Allergan (C), Allergan (R), Bayer (R), Novartis (C), Novartis (R);
Matthias Iwersen, Novartis (E);
Ulrike Michel, Novartis (E);
Martina Junge, Novartis (E);
Peter Geuking, Novartis (E);
Katrin Lorenz, Aerie Pharmaceuticals (F), Alcon (F), Alimera (F), Allergan (F), Bayer (F), Bioeq (F), Boehringer Ingelheim (C), Boehringer Ingelheim (F), Chroma Pharma (C), Chroma Pharma (F), Chroma Pharma (R), Isarna Therapeutics (C), Isarna Therapeutics (F), Novartis (C), Novartis (F), Pfizer (F), Quark Pharmaceuticals (F), Regeneron (F), Roche (C), Roche (F), Santen (F), Shire (F), Synteract HCR (C), Thea (F), Thermogenics (F);
Thomas Ach, Alimera (R), Allergan (R), Macregen Inc. (I), Novartis (R), Roche (C);
Ramin Khoramnia, Alcon (R), Alimera (R), Allergan (R), Bayer Healthcare (R), Novartis (R);
Andreas Schmidt, Novartis (R);
Judith Becker, Novartis (R);
Erik Beeke, Novartis (R);
Mathias Müller-Holz, Novartis (R);
Daniel Barthelmes, Alcon (C), Bayer (F), Bayer (R), Novartis (F), Novartis (R);
Focke Ziemssen, Alcon (R), Alimera (C), Allergan (C), Allergan (R), Bayer Healthcare (C), Bayer Healthcare (R), Biogen (R), Boehringer-Ingelheim (C), Clearside (R), MSD (C), Novartis (C), Novartis (R), NovoNordisk (C), Roche (C), Roche (R)